Chapter 1
Overview of Nanobioceramics
Poon Nian Lim*,Ā¶, Jie Huangā ,||
Mamoru Aizawaā”,** and Eng San Thian*,ā ā
*Department of Mechanical Engineering,
National University of Singapore, 9 Engineering Drive 1,
Singapore 117576, Singapore
ā Department of Mechanical Engineering,
University of London, London WC1E 7JE, UK
ā”Department of Applied Chemistry,
School of Science and Technology,
Meiji University, 1-1-1 Higashimita, Tama-ku,
Kawasaki, Kanagawa 214-8571, Japan
Ā¶[email protected], ||[email protected],
**[email protected], ā ā [email protected] Abstract
Bone is the second most commonly transplanted organ in the human body. The concept of repairing bone injuries has evolved greatly over the last five decades to the third generation of biomaterials. One of the emerging areas of research in the third generation of biomaterials is the integration of nanotechnology into bioceramics. Due to its close chemical similarity to the human bone mineral, nanobioceramic has emerged as a new generation of biomaterials, which aims to create a micro-environment that induces enhanced cell responses leading to osteogenesis. This chapter will thus present an overview of the general characteristics of nanobioceramics. The future prospects and challenges of nanobioceramics will also be covered.
1.1Biomaterials for Bone Repair
Bone is a dynamic and complex tissue that provides structural support and withstands load-bearing for the body. Moreover, it also serves as a reservoir for minerals, supports muscular contraction for mechanical movement, and protects the internal organs.1 Through undergoing remodelling, bone has the innate capacity to regenerate and repair itself upon damage. However, when huge amount of bone is lost in circumstances such as trauma, diseases, or old age, the function of bone is adversely affected. Under such circumstances, bone function can only be restored by surgical reconstruction. Bone repair is a procedure of replacing the defect part with material from either the patientās own body (autografting) or that of a donor (allografting).2,3 Autografts contain living bone cells and growth factors that offer osteogenesis and stimulate induction, hence providing bone ingrowth. Even though autograft is considered the āgold standardā, only a limited amount of bone can be harvested for use in bone repair. In relation to skeletal reconstructive surgery, an alternative has been the use of donated allogenic bone. However, processing (freezing or demineralisation) of the allografts adversely affects the structural integrity of the material and its osteoinductive and osteogenic activity. Hence, its implementation for orthopaedic applications has been hindered by the incomplete remodelling and limited availability. Furthermore, both autografting and allografting involve multiple surgeries and are often associated with the risk of a series of complications such as infection, hematoma, cosmetic disadvantages, post-operative pain, and chronic pain at the donor site.4,5 Thus, autografts and allografts do not always provide the best solution for bone repair. Therefore, all these factors greatly drive the market for synthetic bone alternatives.
The concept of placing implants into the human body has evolved greatly over the last five decades. It began in the 1960s with the first generation of biomaterials designed to achieve matching mechanical properties of the replaced tissues, with a minimal toxic response in the host. At that time, bioinert materials are deemed biocompatible and have been used in the following two areas: (1) permanent prostheses such as hip prosthesis and dental implants and (2) fixation tools for bone fractures such as plates, pins, screws, and rods. Bioinert implants such as stainless steels, cobaltāchromium alloys, titanium alloys, alumina, and zirconia are able to provide mechanical support in load-bearing applications.
However, the body regards these bioinert materials as foreign, triggering fibroblasts to form a fibrous capsule around the implant. The formation of a protective fibrous layer isolated the implant from the host tissue, which created a separation between the implant and the host.6 Thus, bioinert implants could not be integrated into the bone tissue. Furthermore, there were also concerns regarding undesirable tissue responses caused by the released ions and small debris particles from the metallic and ceramics implants, respectively.7 In addition to the issue of undesirable responses, the high mechanical stiffness of metallic implants often resulted in stress shielding and thus bone resorption due to the mismatch of elastic modulus between the implant and bone.8 As a consequence, a second operation is often required to remove the failed bioinert implant. Hence, it soon becomes apparent that bioinert materials are not adequate in eliciting full tissue growth and regeneration.
With this in mind, material scientists begin to partner with physicians to develop the second generation of biomaterials. In the 1980s, this has progressed towards biomaterials that can elicit a controlled action and reaction in the physiological environment, conferring a bioactive or biodegradable behaviour. The interface problem can be resolved with bioactive or biodegradable materials. Bone can directly form an interfacial ābondā with the surface of bioactive materials with no mediation of a fibrous connective tissue interface and further undergo mineralisation. Biodegradable materials exhibit clinically relevant, controlled chemical breakdown and resorption, which can be ultimately replaced by regenerating tissues. During the last 40 years, bioceramics have received significant attention for biomedical applications due to their ability to interact with human biological system. With these favourable biological responses, a wide array of ceramic materials have been used. This ranges from chemically pure oxides to various calcium phosphate-based ceramics,9 bioactive glasses,10 glassceramics,11 and the chemically and microstructurally complex ceramic-matrix composites.12 These bioceramics can be fabricated in a variety of forms to serve various functions in the body repair.13
Calcium phosphate-based ceramics can be fabricated into porous implants, granules, powders, and coatings on metallic implants. For instance, hydroxyapatite (HA) coatings provided osteoconduction in which bones grew onto the coatings and formed mechanically strong interface.13 Bioactive glasses and glass-ceramics were used as middle-ear prostheses, oral implants, and vertebrae replacement for spinal tumours.14 Bioactive composite consisting of HA particles in a polyethylene matrix has become important in the repair and replacement of bones in the middle ear.15
Despite the clinical success of bioinert, bioactive, and biodegradable implants in meeting the medical needs of the rapidly aging population, 30ā50% of the prostheses failed within 10ā25 years, leading to revision surgeries.16 Unlike living tissues, synthetic materials cannot respond to the changing physiological loads or biochemical stimuli. Hence, this limits the lifetime of the synthetic implants. Fifty years of research in the advancement of first- and second-generation biomaterials are limited in the repair and restoration of the body and this signals the need for a shift of the current medical paradigm towards a more biological-based approach for the regeneration of tissues.
This shift occurs at the beginning of 2000s, which brings us to the third generation of biomaterials, the cell- and gene-activating biomaterials that are designed to stimulate specific cellular responses at the molecular level. Third-generation materials are not meant to substitute plainly the materials from previous generations. Instead, they improve the initial physiological cues and bio-activity existing in the second-generation biomaterials, to allow the biomaterials and surrounding environment to adapt, signal, and stimulate specific cellular activity and behaviour in order to regenerate new tissues. The aim to regenerate rather than repair leads to the exploration of tissue engineering and regenerative medicine by using natural signalling pathways and components such as stem cells, growth factors, and peptide sequences, in combination with the synthetic scaffold. Artificial tissues are being fabricated by placing cells within scaffold materials so as to guide cell proliferation and differentiation. Hence, this opens up new possibilities of treatments and applications.
Along this new wave of thinking, one of the emerging areas of research is the integration of nanotechnology into the field of bio-material science. Nanotechnology has opened up a new era of technology, particularly the development of nanostructuring and nanoscale engineering of the biomaterials. The intriguing properties of nanobiomaterials are explored in several ways. Metallic nanoparticles have found significant applications in a wide spectrum of biomedical utilities such as imaging, sensing, drug delivery, and gene targeting.17ā20 Carbon-based nanomaterials including fullerenes, nanotubes, nanodiamonds, and graphene show great promise as a carrier for pharmaceutical agents, components in nanoformulations for the delivery of therapeutic molecules, biosensor, imaging, drug delivery, bacterial inhibition, and photothermal therapy.21ā23 Polymeric nanoparticles have been used as drug carriers,24,25 and nanobioceramics have been used extensively in orthopaedic and cranio-maxillofacial applications.26 Indeed, nanotechnology has evolved rapidly from the discovery phase to the application phase; its potential impact on the healthcare is immense and has pervaded many aspects of the medical field (Table 1.1).27
Driven by the increasing number of patients afflicted with traumatic and non-traumatic conditions, the demand for the reconstruc...